Shroom-Therapy Startup Edges Toward FDA Approval

The feds have designated Compass Pathways’ experimental psilocybin treatment for depression a “breakthrough therapy”

Illustration: Cristina Daura for Bloomberg Businessweek

By Adam Piore

Just a few years ago, if you wanted to hear about the benefits of psychedelic drugs, your best bet was to head over to the parking lot outside the…

You’ll also discover more fresh thinking personalized to your interests and can follow your favorite authors, publications, and topics.
Or, continue in mobile web
Already have an account? Sign in

Medium is an open platform where 170 million readers come to find insightful and dynamic thinking. Here, expert and undiscovered voices alike dive into the heart of any topic and bring new ideas to the surface. Learn more

Follow the writers, publications, and topics that matter to you, and you’ll see them on your homepage and in your inbox. Explore

If you have a story to tell, knowledge to share, or a perspective to offer — welcome home. It’s easy and free to post your thinking on any topic. Write on Medium

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store